Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder

Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder

Abstract Background There is no doubt that genetic factors have the potential to predict the therapeutic outcomes of antidepressants in patients with major depressive disorder (MDD). This study investigated the association between genetic variants involved in serotonin signaling and brain-derived ne...

Full description

Bibliographic Details
Main Authors: Dominika Jarčušková, Ivan Tkáč, Nataša Hlaváčová, Alena Stančáková Yaluri, Miriam Kozárová, Viera Habalová, Lucia Klimčáková, Jozef Židzik, Martin Javorský, Aneta Bednářová
Format: Article
Language:English
Published: BMC 2024-10-01
Series:BMC Psychiatry
Subjects:
Pharmacogenetics
Depression
Escitalopram
Genetic Polymorphisms
SLC6A4
Online Access:https://doi.org/10.1186/s12888-024-06162-8

Internet

https://doi.org/10.1186/s12888-024-06162-8

Similar Items